Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (NASDAQ:SNGX)

2.18
Delayed Data
As of Aug 16
 -0.1108 / -4.84%
Today’s Change
1.90
Today|||52-Week Range
8.50
-3.11%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close2.29
Today’s open2.35
Day’s range2.17 - 2.35
Volume46,715
Average volume (3 months)529,310
Market cap$18.0M
Dividend yield--
Data as of 3:59pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)+55.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+19.16%
P/E ratioNM
Price/Sales0.77
Price/Book1.69

Competitors

 Today’s
change
Today’s
% change
DRIODarioHealth Corp-0.18-8.91%
VTGNVistaGen Therapeutic...+0.11+6.36%
BNTCBenitec Biopharma Lt...+0.18+9.12%
PTIEPain Therapeutics In...+0.03+0.91%
Data as of 08/16/2017

Financials

Last reporting dateAugust 17, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$10.4M
Annual profit (last year)-$3.2M
Net profit margin-31.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer &
Senior Vice President
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts